This webinar will be viewed at the GCA Conference. No link will be provided.
Thursday, August 27, 2026 | 2:00 pm - 3:30 pm (EDT) | 8 AM - 9:30 AM HST
Description:
The proposed federal rescheduling of marijuana has raised important questions about workplace drug testing, safety programs, and employer compliance. While the process is still underway, organizations should understand what a move from Schedule I to Schedule III would—and would not—change. This webinar will separate fact from speculation, examine the potential impact on workplace drug testing and employer policies, explore the intersection of federal and state laws, and provide practical steps employers can take to maintain safe workplaces while preparing for future legal developments.
By attending this webinar, participants will:
Featured Speakers
Nick HartmanDrug Screening Compliance Institute (DSCI)Co-Founder & Managing Partner
William J. Judge JD, LL.M.Drug Screening Compliance Institute (DSCI)Co-Founder, Senior Research Attorney
GCA Conference Room
This webinar series will be viewed at the GCA Conference. No link will be provided.
Price: Member $25 | Non-member $50
Includes snacks and beverage.
Cancellation Policy: A full refund will be given to cancellations made 5 calendar days prior to the class kick-off. After such time, no refunds will be given. Replacements are acceptable and must be submitted via email to gca@gcahawaii.org.
GCA reserves the right to cancel programs up to 5 days prior to the start date if a minimum number of attendees is not met.
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}